Background
Despite accurate diagnostic tests and effective therapies, the management of osteoporosis has been observed to be suboptimal in many settings. We tested the effectiveness of an intervention to improve care in patients at-risk of osteoporosis.
Design
Randomized controlled trial.
Participants
Primary care physicians and their patients at-risk of osteoporosis, including women 65 years and over, men and women 45 and over with a prior fracture, and men and women 45 and over who recently used ≥90 days of oral glucocorticoids.
Intervention
A multifaceted program of education and reminders delivered to primary care physicians as well as mailings and automated telephone calls to patients. Outcome: Either undergoing a bone mineral density (BMD) testing or filling a prescription for a bone-active medication during the 10 months of follow-up.
Results
After the intervention, 144 (14%) patients in the intervention group and 97 (10%) patients in the control group received either a BMD test or filled a prescription for an osteoporosis medication. This represents a 4% absolute increase and a 45% relative increase (95% confidence interval 9–93%, p = 0.01) in osteoporosis management between the intervention and control groups. No differences between groups were observed in the incidence of fracture.
Conclusion
An intervention targeting primary care physicians and their at-risk patients increased the frequency of BMD testing and/or filling prescriptions for osteoporosis medications. However, the absolute percentage of at-risk patients receiving osteoporosis management remained low.
Similar content being viewed by others
References
Morris CA, Cabral D, Cheng H, et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004;19:783–90.
Solomon DH, Morris C, Cheng H, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005;80:194–202.
http://www.ncqa.org/communications/sohc2004/osteoporosis.htm accessed November 21, 2005.
Harrington JT, Broy SB, DeRosa AM, Licata AA, Shewmon, DA. Hip fracture patients are not treated for osteoporosis: a call for action. Arthritis Care Res. 2002;47:651–4.
Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL. Prevention of corticosteroid induced osteoporosis: results of a patient survey. Arthritis Rheum. 1999;42:1736–9.
Yood RA, Harrold LR, Fish L, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001;161:1322–7.
Solomon DH, Katz JN, Jacobs JP, et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis—rates and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002;46:3136–42.
Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med. 2005;353:164–71.
Solomon DH, Connelly MT, Rosen CJ, et al. Factors related to the use of bone densitometry: a survey of 494 physicians in New England. Osteoporos Int. 2003;14:123–9.
Majumdar SR, Rowe BH, Folk D, et al. A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med. 2004;141:366–73.
Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Randomized trial of osteoporosis screening: use of hormone replacement therapy and quality-of-life results. Arch Intern Med. 197;157:2121–5.
Newman ED, Starkey RH, Ayoub WT, et al. Osteoporosis disease management: best practices from the Penn State Geisinger Health System. J Clinic Outcomes Manag. 2000;7:23–8.
Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res. 1999;14:2143–9.
Chevalley T, Hoffmeyer T, Bonjour JP. An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int. 2002;13:450–5.
Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol. 1997;89:321–5.
Gardner MJ, Brophy RH, Bemetrakopoulos D, et al. Interventions to improve osteoporosis treatment following hip fracture. J Bone Jt Surg Am. 2005;87:3–7.
Feldstein AC, Elmer PJ, Smith DH, et al. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized controlled trial. J Am Geriat Soc. 2006;54:450–7.
Soumerai SB, Avorn J. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;263:549–56.
Corkrey R, Parkinson L. Interactive voice response: review of studies 1989–2000. Behav Res Meth Instrum Comput. 2002;34:342–53.
Polinski JM, Patrick AR, Truppo C, et al. Interactive voice response telephone calls to enhance bone mineral density testing. American Journal of Managed Care. 2006;12:321–5.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational outreach to improve blood transfusion practice. JAMA. 1993;270:961–6.
Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing”. N Engl J Med. 1983;308:1457–63.
Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161:1897–1902.
Thomson O’Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits. Cochrane Effective Practice and Organisation of Care Group. Cochrane Database Syst Rev. 2005;4.
Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165:2414–9.
U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004.
Acknowledgment
The study was funded by Merck and Co., Inc. Dr. Solomon is also supported by grants from the NIH (AR48616, AG027066), the Arthritis Foundation, and the Engalitcheff Arthritis Outcomes Initiative. The study data were possessed by the study’s principal investigator (DHS) who guarantees their integrity.
Potential Financial Conflicts of Interest
Drs Weiss and Chen are both employees of Merck and Co., Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Solomon, D.H., Polinski, J.M., Stedman, M. et al. Improving Care of Patients At-Risk for Osteoporosis: A Randomized Controlled Trial. J GEN INTERN MED 22, 362–367 (2007). https://doi.org/10.1007/s11606-006-0099-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-006-0099-7